Table 3.
Cancer | Study | n | Surgery | Cirrhosis (%) | P | Conversion Rate (%) | Blood Loss (mL) | P | R0 resection (%) | Hospital Stay (days) | P | 5-y Survival | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HCC | Han et al3 | 88 | LLR | 62.5 | NS | 9.1 | 500 | NS | 98.9 | NS | 8 | =0.001 | 76.4 mo | NS |
88 | OLR | 59.1 | 525 | 94.3 | 10 | 73.2 mo | ||||||||
Kim et al12 | 29 | LLR | 100 | NS | 23 | 485 | NS | 89.7 | NS | 7.7 | <0.001 | 47.9 mo | NS | |
29 | OLR | 100 | 262 | 96.6 | 13.4 | 59.5 mo | ||||||||
Cheung et al13 | 32 | LLR | 87.5 | NS | — | 150 | =0.001 | 97 | NS | 4 | <0.001 | 76.6 | NS | |
64 | OLR | 79.7 | 300 | 94 | 7 | 57 | ||||||||
Truant et al14 | 36 | LLR | 1001 | 19.4 | 452 | NS | — | 6.5 | =0.003 | 70 | NS | |||
53 | OLR | 1001 | 447 | — | 9.5 | 46 | ||||||||
Hu et al15 | 30 | LLR | 83 | 0 | 520 | NS | — | 13 | <0.01 | 53.3 | NS | |||
30 | OLR | — | 480 | — | 20 | 50 | ||||||||
Lee et al16 | 33 | LLR | 84.8 | =0.038 | 18.2 | 150 | NS | 97 | NS | 5 | <0.001 | 76 | NS | |
50 | OLR | 64 | 240 | 98 | 7 | 76,1 | ||||||||
CRC metastases | Tohme et al4 | 66 | LLR | 4 | 150 | NS | 88 | NS | 4 | <0.001 | 51.3 | NS | ||
66 | OLR | 250 | 89 | 5 | 38.6 | |||||||||
Guerron et al17 | 40 | LLR | 5 | 376 | =0.04 | 1 cm | NS | 3.7 | <0.001 | 892 | NS | |||
40 | OLR | 753 | 1 cm | 6.5 | 812 | |||||||||
Qiu et al18 | 30 | LLR | 6.7 | NS | 6.7 | 215 | <0.001 | 9.9 cm | NS | 7.5 | <0.001 | — | ||
30 | OLR | 10 | 385 | 1 cm | 11.5 | — | ||||||||
Cannon et al19 | 35 | LLR | — | 202 | <0.001 | 97 | p=0.02 | 4.8 | <0.001 | 36 | NS | |||
138 | OLR | 392 | 81 | 7.8 | 37 | |||||||||
Cheung et al20 | 20 | LLR | 0 | 200 | =0.043 | 0.6 cm | NS | 4.5 | =0.021 | 69.4 mo | NS | |||
40 | OLR | 300 | 0.5 cm | 7 | 42.1 mo | |||||||||
Schiffman et al21 | 242 | LLR | — | 262 | =0.049 | 94.5 | NS | 6.5 | =0.007 | 51.4 | NS | |||
386 | OLR | 385 | 87.4 | 8.8 | 45.9 | |||||||||
Fretland et al23 | 133 | LLR | 2 | 300 | NS | 94 | NS | 53h | <0.001 | — | ||||
147 | OLR | 200 | 93 | 96h | — |
All F3 and F4 fibrosis;
2-year survival; 3references 14–17 included in this meta-analysis. [-] information not provided; mo, months; NS, not significant.